JPH0460451B2 - - Google Patents
Info
- Publication number
- JPH0460451B2 JPH0460451B2 JP59502195A JP50219584A JPH0460451B2 JP H0460451 B2 JPH0460451 B2 JP H0460451B2 JP 59502195 A JP59502195 A JP 59502195A JP 50219584 A JP50219584 A JP 50219584A JP H0460451 B2 JPH0460451 B2 JP H0460451B2
- Authority
- JP
- Japan
- Prior art keywords
- arnica
- extraction
- extracted
- extract
- flowers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 241000208983 Arnica Species 0.000 description 21
- 238000000605 extraction Methods 0.000 description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- 239000000284 extract Substances 0.000 description 13
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 12
- 239000000341 volatile oil Substances 0.000 description 12
- 229930009674 sesquiterpene lactone Natural products 0.000 description 11
- 150000002107 sesquiterpene lactone derivatives Chemical class 0.000 description 11
- 239000003814 drug Substances 0.000 description 9
- 229940079593 drug Drugs 0.000 description 9
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 239000013566 allergen Substances 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 229930182486 flavonoid glycoside Natural products 0.000 description 7
- 150000007955 flavonoid glycosides Chemical class 0.000 description 7
- 241000894007 species Species 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- HATRDXDCPOXQJX-UHFFFAOYSA-N Thapsigargin Natural products CCCCCCCC(=O)OC1C(OC(O)C(=C/C)C)C(=C2C3OC(=O)C(C)(O)C3(O)C(CC(C)(OC(=O)C)C12)OC(=O)CCC)C HATRDXDCPOXQJX-UHFFFAOYSA-N 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 229910002092 carbon dioxide Inorganic materials 0.000 description 4
- 238000004809 thin layer chromatography Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000086254 Arnica montana Species 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- 230000002009 allergenic effect Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000010908 decantation Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- BLZVCIGGICSWIG-UHFFFAOYSA-N 2-aminoethoxydiphenylborane Chemical compound C=1C=CC=CC=1B(OCCN)C1=CC=CC=C1 BLZVCIGGICSWIG-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- DCNRYQODUSSOKC-HKHYKUHTSA-N Angustibalin Chemical compound C[C@@H]1C[C@H]2OC(=O)C(=C)[C@H]2[C@H](OC(C)=O)[C@]2(C)C(=O)C=C[C@@H]12 DCNRYQODUSSOKC-HKHYKUHTSA-N 0.000 description 1
- OSSDUQKWVVZIGP-UHFFFAOYSA-N Aromaticin Natural products CC1CC2OC(=O)C(=C)C2CC2(C)C(=O)C=CC12 OSSDUQKWVVZIGP-UHFFFAOYSA-N 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- MQVRGDZCYDEQML-UHFFFAOYSA-N Astragalin Natural products C1=CC(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(CO)O2)O)C(=O)C2=C(O)C=C(O)C=C2O1 MQVRGDZCYDEQML-UHFFFAOYSA-N 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- ZVLOPMNVFLSSAA-UHFFFAOYSA-N Heleanalin Natural products CC1CC2OC(=O)C(=C)C2C(O)C2(C)C(=O)C=CC12 ZVLOPMNVFLSSAA-UHFFFAOYSA-N 0.000 description 1
- RFBYGVGDYMSKTD-UHFFFAOYSA-N Helenalin Natural products CC1CC2OC(=O)C(=C)C2C(O)C3C(C)C(=O)C=C13 RFBYGVGDYMSKTD-UHFFFAOYSA-N 0.000 description 1
- OVSQVDMCBVZWGM-IDRAQACASA-N Hirsutrin Natural products O([C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1)C1=C(c2cc(O)c(O)cc2)Oc2c(c(O)cc(O)c2)C1=O OVSQVDMCBVZWGM-IDRAQACASA-N 0.000 description 1
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 1
- AFTUDGRDUWDYHE-UHFFFAOYSA-N Mexicanin I Natural products CC1CC2OC(=O)C(=C)C2C(O)C3(C)C1CC=C3C AFTUDGRDUWDYHE-UHFFFAOYSA-N 0.000 description 1
- DCNRYQODUSSOKC-UHFFFAOYSA-N Mexicanin-I-acetat Natural products CC1CC2OC(=O)C(=C)C2C(OC(C)=O)C2(C)C(=O)C=CC12 DCNRYQODUSSOKC-UHFFFAOYSA-N 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- USRAFFQOAADTTD-OJIWXCRVSA-N [(3ar,5r,5ar,8ar,9r,9ar)-5,8a-dimethyl-1-methylidene-2,8-dioxo-3a,4,5,5a,9,9a-hexahydroazuleno[6,5-b]furan-9-yl] 2-methylprop-2-enoate Chemical compound C[C@@H]1C[C@H]2OC(=O)C(=C)[C@H]2[C@@H](OC(=O)C(C)=C)[C@]2(C)C(=O)C=C[C@@H]12 USRAFFQOAADTTD-OJIWXCRVSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 208000002029 allergic contact dermatitis Diseases 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 229940089116 arnica extract Drugs 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000002026 chloroform extract Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- ZVLOPMNVFLSSAA-XEPQRQSNSA-N helenalin Chemical compound C[C@@H]1C[C@H]2OC(=O)C(=C)[C@H]2[C@H](O)[C@]2(C)C(=O)C=C[C@@H]12 ZVLOPMNVFLSSAA-XEPQRQSNSA-N 0.000 description 1
- USRAFFQOAADTTD-UHFFFAOYSA-N helenalin methacrylate Natural products CC1CC2OC(=O)C(=C)C2C(OC(=O)C(C)=C)C2(C)C(=O)C=CC12 USRAFFQOAADTTD-UHFFFAOYSA-N 0.000 description 1
- GXMWXESSGGEWEM-UHFFFAOYSA-N isoquercitrin Natural products OCC(O)C1OC(OC2C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)C(O)C1O GXMWXESSGGEWEM-UHFFFAOYSA-N 0.000 description 1
- JPUKWEQWGBDDQB-QSOFNFLRSA-N kaempferol 3-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=CC(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O JPUKWEQWGBDDQB-QSOFNFLRSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000003805 procoagulant Substances 0.000 description 1
- OVSQVDMCBVZWGM-QSOFNFLRSA-N quercetin 3-O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-QSOFNFLRSA-N 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D11/00—Solvent extraction
- B01D11/02—Solvent extraction of solids
- B01D11/0203—Solvent extraction of solids with a supercritical fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Pain & Pain Management (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Rheumatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
請求の範囲
1 アルニカ花からアレルゲンを分離するに当
り、乾燥アルニカ花に、31〜90℃及び70〜500バ
ールで臨界超過CO2を用いて高圧抽出を施しかつ
溶出されたアレルゲン物質及び場合によつては同
伴抽出された精油を圧力及び/又は温度低下によ
つて分離することを特徴とするアルニカ花からア
レルゲンを分離する方法。Claim 1 In separating allergens from arnica flowers, dried arnica flowers are subjected to high-pressure extraction using supercritical CO 2 at 31-90°C and 70-500 bar, and the eluted allergen substances and optionally A method for separating allergens from arnica flowers, which comprises separating the entrained extracted essential oil by reducing pressure and/or temperature.
2 分離を50〜70℃及び300バールで実施する請
求の範囲第1項記載の方法。2. Process according to claim 1, in which the separation is carried out at 50-70°C and 300 bar.
3 抽出のために未粉砕乾燥アルニカ花を使用す
る請求の範囲第1項又は第2項記載の方法。3. The method according to claim 1 or 2, wherein unground dried arnica flowers are used for the extraction.
4 乾燥アルニカ花からアレルゲンのセスキテル
ペンラクトンを分離する請求の範囲第1項から第
3項までのいづれか1項に記載の方法。4. The method according to any one of claims 1 to 3, for separating the allergenic sesquiterpene lactone from dried arnica flowers.
5 アレルゲンを含まないアルニカ花薬種を製造
する請求の範囲第1項から第4項までのいづれか
1項に記載の方法。5. The method according to any one of claims 1 to 4, for producing an allergen-free Arnica flower medicinal species.
技術分野
本発明は、CO2高圧抽出によつてアルニカ花か
らアレルゲンを分離する方法に関する。TECHNICAL FIELD The present invention relates to a method for separating allergens from arnica flowers by CO 2 high pressure extraction.
背景技術
アルニカ・モンタナ(Arnica montana)L.
(キク科)は、数世紀以来中央ヨーロツパの薬宝
の中の極めて重要な薬用植物の一つである。アル
ニカ花(Flores Arnicae)については、全ドイ
ツ薬局方に単行文が見出される。多数のアルニカ
製剤はアルニカ・モンタナの抽出物を含有してい
る。アルニカ製剤の適用の重点は外部使用であ
る。作用は防腐性、消炎性及び血液凝固促進性で
あると特徴づけられている。従つてアルニカ抽出
物は就中創傷治療軟膏において使用されるが、し
かしまた毛髪用油、ローシヨン、薬草シヤンプー
においても使用される。内部適用の場合には、呼
吸及び循環促進性ならびに吸収促進性が認められ
ている。Background technology Arnica montana L.
(Asteraceae) has been one of the most important medicinal plants in the medicinal treasures of central Europe since several centuries. Regarding the Arnica flower (Flores Arnicae), monographs are found in all German Pharmacopoeia. Many arnica preparations contain extracts of Arnica montana. The emphasis of the application of arnica preparations is external use. The action is characterized as antiseptic, anti-inflammatory and procoagulant. Arnica extracts are therefore used primarily in wound treatment ointments, but also in hair oils, lotions, herbal shampoos. When applied internally, respiratory and circulation promoting properties as well as absorption promoting properties have been observed.
アルニカ製剤の薬理作用は、特定の含有物質、
就中精油、フラボノイドグリコシド及び最近の研
究で見出されたセスキテルペンラクトンに起因す
る。アルニカ花の含有物質に関する詳細な論文
は、雑誌“フアルマツイー・イン・ウンゼレル・
ツアイト(Phamazie inunserer Zeit)”、第10
巻、1〜7頁(1981)に掲載されている。 The pharmacological action of arnica preparations is based on the specific substances it contains,
This is mainly due to essential oils, flavonoid glycosides and sesquiterpene lactones found in recent studies. A detailed article on the substances contained in Arnica flowers can be found in the journal “Falmatui in Unzerer”
Phamazie inunserer Zeit”, No. 10
Volume, pages 1-7 (1981).
しかしアルニカ抽出物、例えばアルニカチンキ
を不適切に適用すると、アレルギー性接触皮膚炎
の危険が生じる。このような症例は、“デル・ハ
ウトアールツト(Der Hautarzt)”10〜17頁
(1980)に多数記載されている。接触アレルゲン
としては、セスキテルペンラクトン、ヘレナリ
ン、ヘレナリンアセテート及びヘレナリン−メタ
クリレートが挙げられている。 However, improper application of arnica extracts, such as arnica tincture, poses a risk of allergic contact dermatitis. Many such cases are described in "Der Hautarzt", pages 10-17 (1980). Contact allergens include sesquiterpene lactones, helenalin, helenalin acetate, and helenalin-methacrylate.
ところで、液状CO2を用いるアルニカ花の適当
な処理によつて、前記セスキテルペンラクトン
を、薬理作用にとつて重要な他の含有物質、すな
わちフラボノイドグリコシド及び精油の一部を一
緒に捕捉することなく、定量的に抽出することが
できることが見出された。 By the way, by appropriate treatment of arnica flowers with liquid CO 2 , the sesquiterpene lactones can be removed without trapping together with other contained substances important for pharmacological action, namely flavonoid glycosides and part of the essential oil. , it was found that it can be extracted quantitatively.
発明の開示
したがつて本発明の対象は、アルニカ花からア
レルゲンを分離するに当り、乾燥アルニカ花に31
〜90℃及び70〜500バールで臨界超過CO2を用い
て高圧抽出を施しかつ溶出されたアレルゲン物質
及び場合によつては同伴抽出された精油を圧力及
び/又は温度低下によつて分離することを特徴と
する前記アレルゲンの分離方法である。DISCLOSURE OF THE INVENTION The object of the present invention is therefore to isolate allergens from arnica flowers by applying 31%
High-pressure extraction with supercritical CO 2 at ~90° C. and 70-500 bar and separation of the eluted allergenic substances and optionally entrained extracted essential oils by pressure and/or temperature reduction. The method for separating the allergen is characterized by:
抽出のために、乾燥アルニカ花を例えば滑りロ
ーラーを用いて高圧で粉砕することによつて砕解
してもよい。しかしこの場合には、アレルゲンの
セスキテルペンラクトンの他に精油が定量的に抽
出されるという欠点がある。従つて未粉砕花に抽
出を施すのが有利であつて、この場合にはセスキ
テルペンラクトン分は同様に定量的に抽出される
けれども、精油の主要部分は薬理作用を有する他
の物質と共に被抽出薬種の中に残存している。こ
れは通常アレルゲンを含まないアルニカ抽出物、
チンキ等の抽出製造に用いられる。 For extraction, dried arnica flowers may be crushed, for example by crushing at high pressure using sliding rollers. However, this method has the disadvantage that essential oils are quantitatively extracted in addition to the allergen sesquiterpene lactone. It is therefore advantageous to perform the extraction on unpulverized flowers, in which case the sesquiterpene lactone content is likewise quantitatively extracted, but the main part of the essential oil is extracted along with other substances with pharmacological activity. It remains in the drug. This is usually an allergen-free arnica extract,
Used for extraction and manufacturing of tinctures, etc.
二酸化炭素を用いて圧力下に抽出を行うことは
原理的には公知であつて、多数の文献、例えばケ
ミストリー・アンド・インダストリー
(Chemistry and industry)12、385〜405頁
(1982)ならびにヨーロツパ特許第23680号及び同
第58365号明細書に記載されている。 Extraction under pressure with carbon dioxide is known in principle and is described in numerous publications, such as Chemistry and Industry 12, pp. 385-405 (1982) and European Patent No. It is described in specifications No. 23680 and No. 58365.
抽出は、70〜500バール、好ましくは300バール
の圧力でかつ31〜90℃の温度、好ましくは50〜70
℃で臨界超過CO2を用いて行われる。抽出物の分
離は圧力及び温度低下によつて行われる。未粉砕
薬種の抽出所要時間は約3〜6時間である。 The extraction is carried out at a pressure of 70-500 bar, preferably 300 bar and at a temperature of 31-90 °C, preferably 50-70 °C.
Performed using supercritical CO2 at °C. Separation of the extract is carried out by reducing pressure and temperature. The extraction time of the unground drug species is approximately 3-6 hours.
抽出前及び後の薬種中の含有物質の測定は薄層
クロマトグラフイーにより定量的に行われる。抽
出の完全度はCO2−抽出物の相応の検査によつて
判断することができる。 The substances contained in the drug species before and after extraction are quantitatively measured by thin layer chromatography. The completeness of the extraction can be judged by corresponding examination of the CO2 extract.
フラボノイドグリコシド検査は原則的には
DAB7(付録2、116頁以下)により行う:
乾燥アルニカ花(アルニカ・モンタナ、Flos)
に、フラボノイド検査のためにメタノール(薬種
1g当りメタノール20ml)を用いて抽出を施す。
次に濾過し、濾液を蒸発濃縮して2mlとする。こ
の抽出液をクロロホルム/メタノール(3:1)
中に溶かす。試料100μ1を珪酸ゲルGF254板上に
スポツトしかつ酢酸エチル/蟻酸(無水)/酢
酸/H2O(100:11:11:26)で展開して薄層ク
ロマトグラフイーを行う。検出はメタノール中の
ジフエニルボリルオキシエチルアミンの1%溶液
を噴霧して行う。 In principle, flavonoid glycoside testing is
Performed by DAB7 (Appendix 2, p. 116 et seq.): Dried arnica flowers (Arnica montana, Flos)
Then, extraction is performed using methanol (20 ml of methanol per 1 g of drug) for flavonoid testing.
It is then filtered and the filtrate is evaporated to 2 ml. This extract was mixed with chloroform/methanol (3:1).
Dissolve inside. Thin layer chromatography is performed by spotting 100 μl of a sample onto a silicic acid gel GF 254 plate and developing it with ethyl acetate/formic acid (anhydrous)/acetic acid/H 2 O (100:11:11:26). Detection is carried out by spraying a 1% solution of diphenylboryloxyethylamine in methanol.
セスキテルペンラクトン検査は、C.ヴイルウー
ン(Willuhn)及びH.D.シエーフエル
(Scha¨fer)、フアルマツオイテイツシエ・ツアイ
トウング(Pharmazeutische Zeitung)123、
1803〜1808頁(1978)により行うことができる:
薬種つまり抽出後の残存物5gにベンゾール40
mlを用いて10分間低温抽出を施し、濾過しかつベ
ンゾール5mlで後洗浄する。ベンゾール抽出液を
60〜70℃で蒸発濃縮し、残留物から60%エタノー
ル30mlを用いて振出を行い、次に濾過する。CO2
−抽出物(100mg)をベンゾール10ml中に熱時に
溶かし、濾過しかつ同量の60%エタノールを用い
て4回振出を施す。 Sesquiterpene lactone testing was performed by C. Willuhn and HD Schafer, Pharmazeutische Zeitung 123,
It can be carried out according to pp. 1803-1808 (1978): 40 g of benzol to 5 g of the drug, that is, the residue after extraction.
ml for 10 minutes, filtered and washed with 5 ml of benzene. benzol extract
It is concentrated by evaporation at 60-70°C, and the residue is extracted with 30 ml of 60% ethanol and then filtered. CO2
- The extract (100 mg) is dissolved hot in 10 ml of benzol, filtered and shaken out four times with the same volume of 60% ethanol.
エタノールを除去しかつ水相を補充して20mlに
した後、それぞれ5mlのクロロホルムで5回振出
を行う。集めたクロロホルム抽出液をCaCl2によ
り脱水しかつ蒸発濃縮する。黄色同伴物質を除去
するために、残留物をベンゾール0.5ml中に取り、
中性酸化アルミニウム90〔メルク(Merck)社、
活性段階1〕20gにより石油エーテル/ベンゾー
ル/クロロホルム/メタノール(5:4:1:
2)混合物を用いてクロマトグラフイーを行う。
溶離液の最初の10mlを棄てる。次の20mlを蒸発乾
固し、DC分析のためにベンゾール0.3ml中に取
る。 After removing the ethanol and replenishing the aqueous phase to 20 ml, shakeouts are carried out five times with 5 ml of chloroform each. The combined chloroform extracts are dried over CaCl 2 and concentrated by evaporation. To remove the yellow entrainment, the residue was taken up in 0.5 ml of benzol and
Neutral aluminum oxide 90 [Merck,
Activation step 1] 20g of petroleum ether/benzole/chloroform/methanol (5:4:1:
2) Perform chromatography using the mixture.
Discard the first 10ml of eluent. Evaporate the next 20 ml to dryness and take up in 0.3 ml of benzene for DC analysis.
試料(20〜30μ1)を珪酸ゲルF254−薄層板(メ
ルク社)上にスポツトしかつn−ペンタン/エー
テル(8:17)で展開する。検出は、ツインメル
マン(Zimmermann)試薬〔エタノール中のm
−ジニトロベンゾール及び1.25N KOH(1:1)
の2%溶液〕を噴霧した後紫外線下で行う。 Samples (20-30 μl) are spotted on silicic acid gel F 254 -thin plates (Merck & Co.) and developed with n-pentane/ether (8:17). Detection was performed using Zimmermann's reagent [m in ethanol.
- dinitrobenzole and 1.25N KOH (1:1)
2% solution] under ultraviolet light.
精油の含量測定はDAB8により行う。 The essential oil content is measured using DAB8.
実施例
例 1
精油0.12ml/100gを含有する未粉砕乾燥アル
ニカ花1000gを、高圧抽出装置の抽出容器中で温
度70℃及び圧力300バールで6時間抽出した。分
離は20℃及び60バールで行つた。Examples Example 1 1000 g of unground dried arnica flowers containing 0.12 ml/100 g of essential oil were extracted for 6 hours at a temperature of 70° C. and a pressure of 300 bar in an extraction vessel of a high-pressure extraction device. The separation was carried out at 20°C and 60 bar.
枯草風の芳香を有する黄褐色のペースト状油出
物が得られた。 A yellow-brown pasty oil with a hay-like aroma was obtained.
抽出物の収量は2.8重量%であつた。さらに水
30mlが分離され、デカンテーシヨン及び絞出しに
よつて除去された。抽出物及び被抽出薬種の分析
により次の結果が得られた:
a 抽出物
精油:0.06ml/100gの乾燥原料
水 :3.1ml/100gの乾燥原料
セスキテルペンラクトン:薄層クロマトグラフ
イーにより検出できる
フラボノイドグリコシド:検出できない
b 被抽出薬種
セスキテルペンラクトン:微量しか検出できな
い
フラボノイドグリコシド:薄層クロマトグラフ
イーによりイソケルシトリン、アスト
ラガリン、ルテオリン−7−グリコシ
ド等が検出できる
精油:0.05ml/100gの被抽出薬種
例 2
乾燥アルニカ花1000gを、滑りローラーを用い
て圧力60tで砕解し、次に70℃、300バールでこれ
に4時間抽出を施した。分離は22℃、65バールで
行つた。 The yield of extract was 2.8% by weight. more water
30ml was separated and removed by decantation and squeezing. The following results were obtained from the analysis of the extract and the extracted drug species: a. Extract Essential oil: 0.06 ml/100 g dry raw material Water: 3.1 ml/100 g dry raw material Sesquiterpene lactone: Detectable by thin layer chromatography Flavonoid glycosides: Not detectableb Drug species to be extracted Sesquiterpene lactones: Only trace amounts can be detected Flavonoid glycosides: Isoquercitrin, astragalin, luteolin-7-glycoside, etc. can be detected by thin layer chromatography Essential oils: 0.05ml/100g Example 2 of extracted drug species 1000 g of dried arnica flowers were crushed using a sliding roller at a pressure of 60 tons, and then extracted at 70° C. and 300 bar for 4 hours. Separation was carried out at 22°C and 65 bar.
抽出物6.5重量%及び水25mlが分離された。水
はデカンテーシヨン及び絞出しによつて除去し
た。 6.5% by weight of extract and 25ml of water were separated. Water was removed by decantation and squeezing.
抽出物は、セスキテルペンラクトン全量及び精
油2.2ml/100g(0.14ml/100gの乾燥原料に相
当する)を含有していた。フラボノイドグリコシ
ドは検出できなかつた。 The extract contained total sesquiterpene lactones and essential oil 2.2 ml/100 g (corresponding to 0.14 ml/100 g dry raw material). Flavonoid glycosides could not be detected.
被抽出薬種にはもはやセスキテルペンラクトン
は検出できず、他方精油の含量は0.02ml/100g
であつた。フラボノイドグリコシドは完全に得ら
れた。 Sesquiterpene lactones can no longer be detected in the extracted drug species, while the essential oil content is 0.02ml/100g.
It was hot. Flavonoid glycosides were completely obtained.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3319184.0 | 1983-05-27 | ||
DE19833319184 DE3319184A1 (en) | 1983-05-27 | 1983-05-27 | METHOD FOR SEPARATING ALLERGENS FROM ARNICA BLUETES BY MEANS OF CO (ARROW DOWN) 2 (ARROW DOWN) HIGH PRESSURE EXTRACTION |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS60501456A JPS60501456A (en) | 1985-09-05 |
JPH0460451B2 true JPH0460451B2 (en) | 1992-09-28 |
Family
ID=6199971
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP59502195A Granted JPS60501456A (en) | 1983-05-27 | 1984-05-19 | Method for separating allergens from arnica flowers by CO↓2 high-pressure extraction |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0144368A1 (en) |
JP (1) | JPS60501456A (en) |
DE (1) | DE3319184A1 (en) |
ES (1) | ES532847A0 (en) |
IT (1) | IT1180170B (en) |
WO (1) | WO1984004683A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1190129B (en) * | 1986-06-17 | 1988-02-10 | Indena Spa | OILAGINOUS FRUITS EXTRACTION PROCEDURE |
DE3637826C1 (en) * | 1986-11-06 | 1988-05-11 | Hopfenextraktion Hvg Barth | Process for extracting natural dyes from walnut shells and henna |
US4927652A (en) * | 1987-12-16 | 1990-05-22 | Lever Brothers Company | Process for the extraction of lactones from lipid material |
NL8900652A (en) * | 1989-03-16 | 1990-10-16 | Leti Lab | PRIMARY TOXIC SUBSTANCES OR ALLERGENS, ISOLABLE FROM VEGETABLE MATERIAL, AND METHODS FOR THE PREPARATION AND USE THEREOF. |
EP0464298B1 (en) * | 1990-07-05 | 1995-06-21 | INDENA S.p.A. | Echinacea extracts, a process for the preparation thereof and formulations containing them |
US5120558A (en) * | 1991-05-01 | 1992-06-09 | Norac Technologies Inc. | Process for the supercritical extraction and fractionation of spices |
CA2072400C (en) | 1991-07-05 | 2003-08-19 | Jayaprakash B. Nair | Supercritical extraction of taxanes |
FR2843125B1 (en) | 2002-08-02 | 2012-11-16 | Coletica | ACTIVE PRINCIPLES STIMULATING HUMAN BETA-DEFENSIVE TYPE 2 AND / OR TYPE 3, AND COSMETIC OR PHARMACEUTICAL COMPOSITIONS COMPRISING SUCH ACTIVE INGREDIENTS |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5554003A (en) * | 1978-10-13 | 1980-04-21 | Hag Ag | Extracting treatment method of vegetable and animal material |
JPS5655175A (en) * | 1979-08-02 | 1981-05-15 | Henkel Kgaa | Production of extract of aromatizing agent |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE789002A (en) * | 1971-09-22 | 1973-01-15 | Sori Soc Rech Ind | PROCESS FOR OBTAINING AN EXTRACT OF ARNICA MONTANA |
DE3105557A1 (en) * | 1981-02-16 | 1982-09-09 | Henkel Kgaa | "METHOD FOR OBTAINING INGREDIENTS OF THE CHAMOMILE BY EXTRACTION WITH CARBON DIOXIDE" |
-
1983
- 1983-05-27 DE DE19833319184 patent/DE3319184A1/en not_active Withdrawn
-
1984
- 1984-05-19 WO PCT/EP1984/000151 patent/WO1984004683A1/en not_active Application Discontinuation
- 1984-05-19 JP JP59502195A patent/JPS60501456A/en active Granted
- 1984-05-19 EP EP84901998A patent/EP0144368A1/en not_active Withdrawn
- 1984-05-25 IT IT21097/84A patent/IT1180170B/en active
- 1984-05-25 ES ES532847A patent/ES532847A0/en active Granted
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5554003A (en) * | 1978-10-13 | 1980-04-21 | Hag Ag | Extracting treatment method of vegetable and animal material |
JPS5655175A (en) * | 1979-08-02 | 1981-05-15 | Henkel Kgaa | Production of extract of aromatizing agent |
Also Published As
Publication number | Publication date |
---|---|
DE3319184A1 (en) | 1984-11-29 |
IT8421097A1 (en) | 1985-11-25 |
ES8502864A1 (en) | 1985-02-01 |
IT1180170B (en) | 1987-09-23 |
WO1984004683A1 (en) | 1984-12-06 |
EP0144368A1 (en) | 1985-06-19 |
ES532847A0 (en) | 1985-02-01 |
JPS60501456A (en) | 1985-09-05 |
IT8421097A0 (en) | 1984-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6228996B1 (en) | Process for extracting sweet diterpene glycosides | |
KR0167122B1 (en) | Process or preparation of poor pesticide active principles concentrates from plants | |
CN102295668B (en) | Method for preparing high-purity steviosides from stevia | |
US20080254149A1 (en) | Recovery of Residual Plant Components After Distillation of Essential Oils | |
DE60320534T2 (en) | METHOD FOR THE QUALITY CONTROL OF A HERBED MEDICINE | |
JPH0460451B2 (en) | ||
CN109730359A (en) | Triterpene compound in a kind of adiantum cpilus-veneris and preparation method thereof and the application in electronic cigarette | |
CN106146383B (en) | A kind of iso-indoles alkaloid compound, preparation method and application in tobacco | |
CN101838299A (en) | Method for separating and purifying natural acteoside | |
CN104957761B (en) | Free state and the application in Medicated cigarette of the bound form aroma material in fruit | |
JP2010070468A5 (en) | ||
Milevskaya et al. | Methods for the extraction of biologically active substances from medicinal plants based on an example of St. John’s wort components | |
CN105837546B (en) | A kind of method that alnusenone, pinocembrin, cardamomin, Alpinetin are isolated and purified from one's early teens | |
US20080306141A1 (en) | Method of Extraction of Catechin Type-A Proanthocyanidins | |
CN107298642A (en) | A kind of method for extraction and purification of 6 salad oil | |
Akbar et al. | Use of Strychnos nux-vomica (Azraqi) seeds in Unani system of medicine: role of detoxification | |
JP3665298B2 (en) | Extraction method of triterpene | |
WO2000023090A1 (en) | Process for removing impurities from natural product extracts | |
CN101456803A (en) | Method for purifying hypericin | |
CN108033984A (en) | A kind of caffeic acid glucoside compound, its preparation method and application | |
Mroczek et al. | Optimization of extraction of pyrrolizidine alkaloids from plant material | |
DK175030B1 (en) | Process for the production of chamomile oil with high natural content of polyyn compounds | |
Ashraf-Khorassani et al. | Supercritical fluid extraction of michellamines A and B from ancistrocladus korupensis leaves | |
Cioaca et al. | Quantitative determination of hellebrin in the rhizomes and roots of Helleborus purpurascens W. et K. | |
JP2740043B2 (en) | Whitening cosmetics |